Abstract:
Phenylsulfonamido compounds that inhibit genome-wide hypomethylation and can be used to treat cancer, including melanoma, prostate cancer, pancreatic cancer, breast cancer, colon cancer, lung cancer, ovarian cancer, and glioblastoma, are provided.
Abstract:
Provided herein are a method of Ru(II)-catalyzed enantioselective synthesis of a cyclic compound and cyclic compounds formed therefrom. The method includes providing a precursor compound having an unfunctionalized C-H bond and activating the unfunctionalized C-H bond by reacting the precursor compound in the presence of co-catalysts including a Ru(II) arene complex and a chiral transient directing group (CTDG).
Abstract:
Provided herein are pentafluorobenzenesulfonamide compounds of Formula (I), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases. These compounds are covalent small molecule inhibitors, more specifically inhibitors of tubulin polymerization.
Abstract:
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a phenyl-sulfonic amide (or similar) structure which function as agonists of mucolipin 1 (ML1), and their use as therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and related disorders.
Abstract:
Provided herein are methods for treating a disease, such as cancer, the methods including administering one or more N -aryl benezenesulfonamides or analogs thereof to a subject in need thereof.
Abstract:
Beschrieben werden Farbentwickler der Formel (I) Ar 1 -SO 2 -NH-C 6 H 4 -SO 2 -C 6 H 4 -NH-CO-NH-Ar 2 (I), ein wärmeempfindliches Aufzeichnungsmaterial, umfassend ein Trägersubstrat sowie mindestens einen Farbbildner und mindestens einen phenolfreien Farbentwickler enthaltende wärmeempfindliche farbbildende Schicht, wobei der mindestens eine Farbentwickler die Verbindung der Formel (I) ist, und ein Verfahren zur Herstellung dieses wärmeempfindlichen Aufzeichnungsmaterials.
Abstract:
본 발명은 신규 화합물 및 상기 화합물을 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학 조성물에 관한 것으로, 에이엠피-활성 단백질 키나아제 활성 효능 및 인 실리코상 결합능이 좋은 모체 구조에서 화학적 변형(chemical modification)을 진행하여 얻어진 신규 화합물은 에이엠피-활성 단백질 키나아제(AMP-activated protein kinase;AMPK) 효소 활성화를 효과적으로 유도하여 퇴행성 신경질환을 효과적으로 예방 또는 치료할 수 있다.
Abstract:
The Present invention relates to solid state forms of (2E)-N-hydroxy-3-[3-(N-phenyl sulfamoyl)phenyl]prop-2-enamide represented by the following structural formula-1 and process for the preparation thereof.